why did fda stop tirzepatide FDA's decision creates uncertainty for patients—and leads to a lawsuit FDA confirms tirzepatide shortage is

The American Diabetes Association and injection technique consensus guidelines support that 4 mm pen needles are effective across all BMI categories when injections are administered correctly

The added glucagon activity appears to boost metabolic rate and fat burning, which likely explains the greater weight loss seen in trials

GLP-1 receptor agonists such as Ozempic (semaglutide) have gained widespread popularity for treating type 2 diabetes and aiding weight loss

Rybelsus can cause side effects like nausea, vomiting, and diarrhoea, which may lead to dehydration if not managed properly

Choosing the injection site